<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Local intra-arterial fibrinolysis (LIF) is an effective treatment for selected patients in <z:hpo ids='HP_0011009'>acute</z:hpo> thromboembolic occlusion of the middle cerebral artery, vertebrobasilar system or ophthalmic artery </plain></SENT>
<SENT sid="1" pm="."><plain>However, the risk/benefit ratio of thrombolysis in patient subgroups requires classification </plain></SENT>
<SENT sid="2" pm="."><plain>Advanced age has been regarded as a prognostic factor for poor clinical outcome </plain></SENT>
<SENT sid="3" pm="."><plain>We report our experience with LIF in seven patients with a mean age of 79 years (range 76-83 years) who represented thromboembolic occlusion of the basilar, middle cerebral or pericallosal arteries </plain></SENT>
<SENT sid="4" pm="."><plain>We discuss why advanced age need not contraindicate LIF </plain></SENT>
</text></document>